Walleye Capital LLC Aclaris Therapeutics, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $1.48 Million - $2.47 Million	-225,618 Reduced 66.05%	115,962 $794,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $1.76 Million - $2.38 Million	223,656 Added 189.66%	341,580 $3.54 Million
Q1 2023 May 15, 2023	SELL	$7.07 - $17.95 $2.13 Million - $5.41 Million	-301,160 Reduced 71.86%	117,924 $954,000
Q4 2022 Feb 14, 2023	BUY	$14.33 - $18.37 $2.14 Million - $2.74 Million	149,136 Added 55.25%	419,084 $6.6 Million
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $3.53 Million - $4.92 Million	269,948 New	269,948 $4.25 Million
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $100,721 - $185,310	-10,341 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$12.27 - $18.49 $126,884 - $191,205	10,341 New	10,341 $150,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $43,450 - $135,850	-55,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.13 - $7.06 $117,150 - $388,300	55,000 New	55,000 $120,000

53.9M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $176M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.